Please use this identifier to cite or link to this item: https://www.arca.fiocruz.br/handle/icict/32178
Full metadata record
DC FieldValue
dc.contributor.authorSabino, Bruno
dc.contributor.authorLessa, Marcos A.
dc.contributor.authorNascimento, Alessandro R.
dc.contributor.authorRodrigues, Carlos A. B.
dc.contributor.authorHenriques, Maria das Graças
dc.contributor.authorGarzoni, Luciana R.
dc.contributor.authorLevy, Bernard I.
dc.contributor.authorTibiriçá, Eduardo
dc.date.accessioned2019-03-20T14:13:49Z
dc.date.available2019-03-20T14:13:49Z
dc.date.issued2008
dc.identifier.citationSABINO, Bruno et al. Effects of Antihypertensive Drugs on Capillary Rarefaction in Spontaneously Hypertensive Rats: Intravital Microscopy and Histologic Analysis. J. Cardiovasc. Pharmacol., v. 51, n. 4, Apr. 2008.
dc.identifier.issn0160-2446
dc.identifier.urihttps://www.arca.fiocruz.br/handle/icict/32178
dc.language.isoeng
dc.publisherLippincott, Williams & Wilkins
dc.rightsrestricted access
dc.subject.otherBloqueador de canal de cálcio
dc.subject.otherCapilaroscopia intravital
dc.subject.otherAntagonista do receptor AT1
dc.subject.otherHipertensão
dc.titleEffects of Antihypertensive Drugs on Capillary Rarefaction in Spontaneously Hypertensive Rats: Intravital Microscopy and Histologic Analysis
dc.typeArticle
dc.description.abstractenWe investigated the effects of chronic oral antihypertensive treatment on functional and structural capillary rarefaction in spontaneously hypertensive rats (SHR). Wistar Kyoto rats (WKY) were used as a normotensive control group. In untreated rats, intravital videomicroscopy showed that functional capillary density was lower in SHR skeletal muscle (WKY 395 6 17 and SHR 258 6 13 capillaries/mm2, P , 0.01) and ear skin (WKY 391 6 18 and SHR 210 6 15 capillaries/mm2, P , 0.01). A linear relationship was seen between skeletal muscle and skin capillary densities (r = 0.654, P , 0.0001). Histologic analysis showed that SHR had a lower capillaryto- fiber ratio in the skeletal muscle (WKY 1.74 6 0.08 and SHR 1.40 6 0.06, P , 0.01). Capillary volume density-to-fiber volume density ratio in the left ventricle of SHR was also reduced (WKY 0.55 6 0.09 and SHR 0.42 6 0.09, P , 0.01). The animals were treated with the angiotensin-converting enzyme (ACE) inhibitor enalapril, the angiotensin II type I receptor (AT1) receptor antagonist losartan, the b-blocker atenolol, or the calcium channel blocker nifedipine, resulting in similar reductions in systolic blood pressure (19.8%, 19.1%, 17.4%, and 18.2%, respectively, P . 0.05). Atenolol did not induce any change in functional capillary density of SHR. Losartan and nifedipine completely reversed functional capillary rarefaction in both muscle and cutaneous tissues, whereas enalapril significantly increased functional capillary density only in the skin. The skeletal muscle capillary-to-fiber ratio was normalized by enalapril, losartan, and nifedipine. Treatments with enalapril or losartan normalized the cardiac structural capillary rarefaction of SHRs, whereas atenolol and nifedipine had no effect. Our results suggest that different pharmacologic classes of antihypertensive drugs with similar effect on blood pressure differ in terms of their effect on the microcirculation.
dc.creator.affilliationFundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Farmacologia Neuro-Cardiovascular. Rio de Janeiro, RJ. Brasil.
dc.creator.affilliationFundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Farmacologia Neuro-Cardiovascular. Rio de Janeiro, RJ. Brasil.
dc.creator.affilliationFundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Farmacologia Neuro-Cardiovascular. Rio de Janeiro, RJ. Brasil.
dc.creator.affilliationInstituto de Tecnologia de Drogas. Departamento de Farmacologia Aplicada. Rio de Janeiro, RJ, Brasil.
dc.creator.affilliationInstituto de Tecnologia de Drogas. Departamento de Farmacologia Aplicada. Rio de Janeiro, RJ, Brasil.
dc.creator.affilliationFundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Farmacologia Neuro-Cardiovascular. Rio de Janeiro, RJ. Brasil.
dc.creator.affilliationHópital Lariboisiére. Cardiovascular Research Center. Paris, France.
dc.creator.affilliationFundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Farmacologia Neuro-Cardiovascular. Rio de Janeiro, RJ. Brasil.
dc.subject.enCapillary rarefaction
dc.subject.enIntravital capillaroscopy
dc.subject.enSHR
dc.subject.enAT1 receptor antagonist
dc.subject.enb-blocker
dc.subject.enACE inhibitor
dc.subject.enCalcium channel blocker
dc.subject.decsRatos Endogâmicos SHR
dc.identifier.eissn1533-4023
Appears in Collections:IOC - Artigos de Periódicos

Files in This Item:
File Description SizeFormat 
Eduardotibiriça_Brunosabibo_etal_IOC_2008.pdf621.95 kBAdobe PDF    Request a copy


FacebookTwitterDeliciousLinkedInGoogle BookmarksBibTex Format mendeley Endnote DiggMySpace

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.